Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
TACE+sorafenib
COMBINATION_PRODUCT
2 trials
Sponsors
Eastern Hepatobiliary Surgery Hospital
, Sun Yat-sen University
Conditions
Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
Sorafenib
Transarterial Chemoembolization
Phase 3
TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma
Completed
NCT04103398
Sun Yat-sen University
Hepatocellular Carcinoma, Sorafenib, Transarterial Chemoembolization
Start: 2019-10-02
End: 2023-12-31
Updated: 2024-02-28
Unknown Phase
Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma
NCT02150317
Eastern Hepatobiliary Surgery Hospital
Advanced Hepatocellular Carcinoma
Start: 2014-01-31
End: 2016-12-31
Target: 180
Updated: 2016-03-29
Related Papers
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma
JAMA Oncology
2024-06-20
37 citations